A Search Service for Abbreviation / Long Form

■ Abbreviation / Long Form : PASMCs / PA smooth muscle cells

[Related PubMed/MEDLINE]
Total Number of Papers: 22
[Entries Per Page]
 per page
Page Control
Page: of
Abbreviation:   PASMCs  (>> Co-occurring Abbreviation)
Long Form:   PA smooth muscle cells
 Abbreviation Variation
 Long Form Variation
 Pair(Abbreviation/Long Form) Variation
No. Year Title Co-occurring Abbreviation
2022 Important Functions and Molecular Mechanisms of Mitochondrial Redox Signaling in Pulmonary Hypertension. NF-kappaB, PA, PH, RISP, ROS
2022 Orai1 Inhibitors as Potential Treatments for Pulmonary Arterial Hypertension. HPASMCs, PA, PAH, PAH, PH, siRNA
2021 Implication of EZH2 in the Pro-Proliferative and Apoptosis-Resistant Phenotype of Pulmonary Artery Smooth Muscle Cells in PAH: A Transcriptomic and Proteomic Approach. EZH2, PA, PAH
2021 Increased intracellular Cl- concentration in pulmonary arterial myocytes is associated with chronic hypoxic pulmonary hypertension. CHPH, KCC, NKCC1, PAs, PH
2021 Preclinical Investigation of Trifluoperazine as a Novel Therapeutic Agent for the Treatment of Pulmonary Arterial Hypertension. FOXO3, PAH, PAs, TFP
2021 Targeted delivery of baicalein-p53 complex to smooth muscle cells reverses pulmonary hypertension. GA, GLUT1, NLS, PA, PAH
2020 PIM1 (Moloney Murine Leukemia Provirus Integration Site) Inhibition Decreases the Nonhomologous End-Joining DNA Damage Repair Signaling Pathway in Pulmonary Hypertension. PAH, PAs
2020 Transcriptomic analysis of pulmonary artery smooth muscle cells identifies new potential therapeutic targets for idiopathic pulmonary arterial hypertension. DE, GPCR, IPAH, PA
2019 Activation of Kv 7 channels as a novel mechanism for NO/cGMP-induced pulmonary vasodilation. DEA-NO, PA
10  2019 Fast relaxation and desensitization of angiotensin II contraction in the pulmonary artery via AT1R and Akt-mediated phosphorylation of muscular eNOS. Ang II, HPASMCs, PAs
11  2017 Chloroquine is a potent pulmonary vasodilator that attenuates hypoxia-induced pulmonary hypertension. HPH, PA
12  2017 Dual ETA/ETB blockade with macitentan improves both vascular remodeling and angiogenesis in pulmonary arterial hypertension. ET-1, PA, PAECs, PAH, RV
13  2017 Visceral adipose tissue-derived serine protease inhibitor prevents the development of monocrotaline-induced pulmonary arterial hypertension in rats. IL, IPA, MCT, MMP, PA, ROS
14  2016 Wall stretch and thromboxane A₂ activate NO synthase (eNOS) in pulmonary arterial smooth muscle cells via H₂O₂ and Akt-dependent phosphorylation. eNOS, NOS, PAs, TXA2
15  2014 Integrative understanding of hypoxic pulmonary vasoconstriction using in vitro models: from ventilated/perfused lung to single arterial myocyte. PA
16  2014 The sphingosine kinase 1/sphingosine-1-phosphate pathway in pulmonary arterial hypertension. HPH, PAH, PAs, S1P, S1PR2, SphKs
17  2011 Alteration of pulmonary artery integrin levels in chronic hypoxia and monocrotaline-induced pulmonary hypertension. ECM, PAs
18  2010 Mitochondrial oxidant stress increases PDE5 activity in persistent pulmonary hypertension of the newborn. PAs, PDE5, PPHN
19  2010 Role of the G-protein and tyrosine kinase--Rho/ROK pathways in 15-hydroxyeicosatetraenoic acid induced pulmonary vasoconstriction in hypoxic rats. 15-HETE, 15-LO, PA, ROK
20  2009 Prolonged hypoxia increases ROS signaling and RhoA activation in pulmonary artery smooth muscle and endothelial cells. HPV, ROS
21  2000 Angiotensin IV-mediated pulmonary artery vasorelaxation is due to endothelial intracellular calcium release. Ang, PA, PI
22  1999 Angiotensin II activates MAPK and stimulates growth of human pulmonary artery smooth muscle via AT1 receptors. Ang, AT1, AT2, MAPK, PA